Precision medicine for multiple sclerosis promotes preventative medicine.

Area of Science:

• Neuroimmunology
• Neurology

Background:

• Multiple sclerosis (MS) is a chronic, incurable neurological disease causing significant disability in young adults.
• Current precision medicine approaches for MS focus on diagnosis, treatment, and management using various patient data.
• The highly variable disease course in MS presents unique challenges for precision medicine.

Purpose of the Study:

• To explore the optimal strategy for precision medicine in multiple sclerosis (MS).
• To determine if precision medicine for MS should emphasize disease prevention and lifestyle modifications.
• To investigate the role of modifiable factors in reducing MS-related disability.

Main Methods:

• Review of current precision medicine strategies in MS.
• Analysis of the temporal variability of MS disease behavior.
• Consideration of advancements in neuroimmunology and biomarker development.

Main Results:

• Precision medicine for MS requires a tailored approach considering subtype, clinical status, and biomarkers.
• The variability of MS necessitates a focus beyond disease-modifying therapies.
• Modifiable factors represent a promising avenue for reducing future disability.

Conclusions:

• Precision medicine for MS should integrate disease prevention and lifestyle modifications.
• Focusing on modifiable factors can help mitigate future disability in MS patients.
• Further research into predictive biomarkers is needed, but current success lies in managing lifestyle influences.